Article

Decreased Expression of T-Cell-Associated Immune Markers Predicts Poor Prognosis in Patients with Advanced Follicular Lymphoma Received Rituximab Plus Bendamustine

2021-07-08

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Several clinical risk stratification models have been proposed to predict the clinical outcomes of follicular lymphoma (FL) cases, however, few reports are available to predict prognosis of FL cases receiving bendamustine-based regimens. We previously examined the utility of rituximab-bendamustine (RB) treatment for newly diagnosed advanced FL, who showed non-op...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e03f3a38-962d-59a6-826e-272042e868f3
DOI: 10.21203/rs.3.rs-648976/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Decreased Expression of T-Cell-Associated Immune Markers Predicts Poor Prognosis in Patients with Advanced Follicular Lymphoma Received Rituximab Plus BendamustineDOI 10.21203/rs.3.rs-648976/v1Read

Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma.Semantic proximity Read

Mutations associated with progression in follicular lymphoma predict inferior outcomes at diagnosis: Alliance A151303.Semantic proximity Read

Genomic landscape of follicular lymphoma across a wide spectrum of clinical behaviors.Semantic proximity Read

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry.Semantic proximity Read

Integrative genomic and transcriptomic analysis reveals genetic alterations associated with the early progression of follicular lymphoma.Semantic proximity Read

Advances in the multi-omics landscape of follicular lymphomaSemantic proximity Read

The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas.Semantic proximity Read

Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement.Semantic proximity Read

EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment.Semantic proximity Read

The follicular lymphoma epigenome regulates its microenvironment.Semantic proximity Read

Follicular lymphoma, a B cell malignancy addicted to epigenetic mutations.Semantic proximity Read

Genomic alterations important for the prognosis in patients with follicular lymphoma treated in SWOG study S0016Semantic proximity Read